This data set includes cities in the United States, Puerto Rico and the U.S. Virgin Islands. These cities were collected from the 1970 National Atlas of the United States. Where applicable, U.S. Census Bureau codes for named populated places were associated with each name to allow additional information to be attached. The Geographic Names Information System (GNIS) was also used as a source for additional information. This is a revised version of the December, 2003, data set.

This layer is sourced from maps.bts.dot.gov.

A dataset listing Georgia cities by population for 2024.

This dataset includes basic data about all US cities with a population over 100.000 (333 cities)

Source: https://en.wikipedia.org/wiki/List_of_United_States_cities_by_population

Coordinates of cities have been geocoded using https://rapidapi.com/GeocodeSupport/api/forward-reverse-geocoding/

Rows description:

City: Name of city State: Name of state Latitude, Longitude, Population_estimate_2022: Estimated population in 2022 Population_2020: Population figure from 2020 census Change_population: % change in population between 2022 and 2020 Land_area: City land area in sq. mi. Population_density_2020: density of population per sq. mi. in 2020

A dataset listing Washington cities by population for 2024.

A range of indicators for a selection of cities from the New York City Global City database.

Dataset includes the following:

Geography

City Area (km2)

Metro Area (km2)

People

City Population (millions)

Metro Population (millions)

Foreign Born

Annual Population Growth

Economy

GDP Per Capita (thousands $, PPP rates, per resident)

Primary Industry

Secondary Industry

Share of Global 500 Companies (%)

Unemployment Rate

Poverty Rate

Transportation

Public Transportation

Mass Transit Commuters

Major Airports

Major Ports

Education

Students Enrolled in Higher Education

Percent of Population with Higher Education (%)

Higher Education Institutions

Tourism

Total Tourists Annually (millions)

Foreign Tourists Annually (millions)

Domestic Tourists Annually (millions)

Annual Tourism Revenue ($US billions)

Hotel Rooms (thousands)

Health

Infant Mortality (Deaths per 1,000 Births)

Life Expectancy in Years (Male)

Life Expectancy in Years (Female)

Physicians per 100,000 People

Number of Hospitals

Anti-Smoking Legislation

Culture

Number of Museums

Number of Cultural and Arts Organizations

Environment

Green Spaces (km2)

Air Quality

Laws or Regulations to Improve Energy Efficiency

Retrofitted City Vehicle Fleet

Bike Share Program

A dataset listing Wisconsin cities by population for 2024.

A dataset listing Maine cities by population for 2024.

A dataset listing New Mexico cities by population for 2024.

A dataset listing Mississippi cities by population for 2024.

A dataset listing Louisiana cities by population for 2024.

A dataset listing Utah cities by population for 2024.

A dataset listing Colorado cities by population for 2024.

This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by ZIP Code Tabulation Area (ZCTA) neighborhood poverty group. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/totals/antibody-by-poverty.csv Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level. These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents. In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders.) Neighborhood-level poverty groups were classified in a manner consistent with Health Department practices to describe and monitor disparities in health in NYC. Neighborhood poverty measures are defined as the percentage of people earning below the Federal Poverty Threshold (FPT) within a ZCTA. The standard cut-points for defining categories of neighborhood-level poverty in NYC are: • Low: <10% of residents in ZCTA living below the FPT • Medium: 10% to <20% • High: 20% to <30% • Very high: ≥30% residents living below the FPT The ZCTAs used for classification reflect the first non-missing address within NYC for each person reported with an antibody test result. Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Rates for poverty were calculated using direct standardization for age at diagnosis and weighting by the US 2000 standard population. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020. Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis will almost certain

A dataset listing Indiana cities by population for 2024.

DPH note about change from 7-day to 14-day metrics: As of 10/15/2020, this dataset is no longer being updated. Starting on 10/15/2020, these metrics will be calculated using a 14-day average rather than a 7-day average. The new dataset using 14-day averages can be accessed here: https://data.ct.gov/Health-and-Human-Services/COVID-19-case-rate-per-100-000-population-and-perc/hree-nys2

As you know, we are learning more about COVID-19 all the time, including the best ways to measure COVID-19 activity in our communities. CT DPH has decided to shift to 14-day rates because these are more stable, particularly at the town level, as compared to 7-day rates. In addition, since the school indicators were initially published by DPH last summer, CDC has recommended 14-day rates and other states (e.g., Massachusetts) have started to implement 14-day metrics for monitoring COVID transmission as well.

With respect to geography, we also have learned that many people are looking at the town-level data to inform decision making, despite emphasis on the county-level metrics in the published addenda. This is understandable as there has been variation within counties in COVID-19 activity (for example, rates that are higher in one town than in most other towns in the county).

This dataset includes a weekly count and weekly rate per 100,000 population for COVID-19 cases, a weekly count of COVID-19 PCR diagnostic tests, and a weekly percent positivity rate for tests among people living in community settings. Dates are based on date of specimen collection (cases and positivity).

A person is considered a new case only upon their first COVID-19 testing result because a case is defined as an instance or bout of illness. If they are tested again subsequently and are still positive, it still counts toward the test positivity metric but they are not considered another case.

These case and test counts do not include cases or tests among people residing in congregate settings, such as nursing homes, assisted living facilities, or correctional facilities.

These data are updated weekly; the previous week period for each dataset is the previous Sunday-Saturday, known as an MMWR week (https://wwwn.cdc.gov/nndss/document/MMWR_week_overview.pdf). The date listed is the date the dataset was last updated and corresponds to a reporting period of the previous MMWR week. For instance, the data for 8/20/2020 corresponds to a reporting period of 8/9/2020-8/15/2020.

Notes: 9/25/2020: Data for Mansfield and Middletown for the week of Sept 13-19 were unavailable at the time of reporting due to delays in lab reporting.

A dataset listing Virginia cities by population for 2024.

This multi-city human mobility dataset contains data from 4 metropolitan areas (cities A, B, C, D), somewhere in Japan. Each city is divided into 500 meters x 500 meters cells, which span a 200 x 200 grid. The human mobility datasets contain the movement of individuals across a 75-day period, discretized into 30-minute intervals and 500-meter grid cells. Each city contains the movement data of 100,000, 25,000, 20,000, and 6,000 individuals, respectively.

While the name or location of the city is not disclosed, the participants are provided with points-of-interest (POIs; e.g., restaurants, parks) data for each grid cell (~85 dimensional vector) for the four cities as supplementary information (e.g., POIdata_cityA). The list of 85 POI categories can be found in POI_datacategories.csv.

This dataset was used for the HuMob Data Challenge 2024 competition. For more details, see https://wp.nyu.edu/humobchallenge2024/

Researchers may use this dataset for publications and reports, as long as: 1) Users shall not carry out activities that involve unethical usage of the data, including attempts at re-identifying data subjects, harming individuals, or damaging companies, and 2) The Data Descriptor paper of an earlier version of the dataset (citation below) needs to be cited when using the data for research and/or commercial purposes. Downloading this dataset implies agreement with the above two conditions.

Yabe, T., Tsubouchi, K., Shimizu, T., Sekimoto, Y., Sezaki, K., Moro, E., & Pentland, A. (2024). YJMob100K: City-scale and longitudinal dataset of anonymized human mobility trajectories. Scientific Data, 11(1), 397. https://www.nature.com/articles/s41597-024-03237-9

This Common Operational Dataset on Population Statistics (COD-PS) is estimated using baseline information from the 2001 Population Census of Ukraine and annual birth and death registration data since the last census.

REFERENCE YEAR: 2022

The COD-PS is age- and sex-disaggregated at ADM-1 level (i.e. Oblast) and has a reference date of 1 January, 2022.

The ukr_admpop_2022.xlsx spreadsheet includes a table of sex and age disaggregated 2022 projected population statistics of the 30 administrative level 4 features that correspond to cities of more than 100,000 people (excluding Kyiv city).

These tables are suitable for database or GIS linkage to the Ukraine - Subnational Administrative Boundaries and Ukraine - Subnational Edge-matched Administrative Boundaries layers using the ADM0, and ADM2_PCODE fields.

This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by week of testing. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/trends/antibody-by-week.csv Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level. These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents. In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders.) Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020. Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis will almost certainly be miscalculating or counting the same values multiple times. To analyze the most current data, only use the latest extract date. Antibody tests that are missing dates are not included in the dataset; as dates are identified, these events are added. Lags between occurrence and report of cases and tests can be assessed by comparing counts and rates across multiple data extract dates. For further details, visit: • https://www1.nyc.gov/site/doh/covid/covid-19-data.page • https://github.com/nychealth/coronavirus-data

This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by sex. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/totals/antibody-by-sex.csv Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level. These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents. In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders.) Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020. Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis will almost certainly be miscalculating or counting the same values multiple times. To analyze the most current data, only use the latest extract date. Antibody tests that are missing dates are not included in the dataset; as dates are identified, these events are added. Lags between occurrence and report of cases and tests can be assessed by comparing counts and rates across multiple data extract dates. For further details, visit: • https://www1.nyc.gov/site/doh/covid/covid-19-data.page • https://github.com/nychealth/coronavirus-data